- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02119429
Pumpkin Seed Oil Supplementation in Premenopausal Women
The Effect of Pumpkin Seed Oil Supplementation on Blood Pressure in Premenopausal Women
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The research study will be conducted over a 12-week period. Overall, each participant will meet with the researcher three times. During the first visit, after the participant has signed the consent form, their blood pressure will be taken with a digital blood pressure monitor. If her systolic blood pressure is greater than 140 mmHg or her diastolic blood pressure is greater than 90 mmHg, she will not be eligible to take part in this study. If the participant is able to take part in this study, she will be given a code number to protect confidentiality and randomly assigned to one of two groups, Group I or Group II. The participant will then be asked to state their age, ethnicity, menopausal status, and whether or not they are taking oral contraceptives. Next, height and weight will be taken with an instrument called a Health-O-Meter. Body mass index (BMI) and percent body fat will be calculated using an instrument called a Body Composition Analyzer. After all measurements are taken, participants will be given instructions on how to keep a 3-day diet and supplement diary. A booklet will be provided to help them record their diet for two nonconsecutive week days and one weekend day. The 3-day diet and supplement diary is to be completed during the week between the first and second session with the researcher. During this session the participant will be asked to complete a food frequency questionnaire to help the researcher asses the phytoestrogen content of her diet. At the end of the first session, the researcher will schedule a second session with the participant.
The second session will take place one week after the first session. During the second session, measurements taken will be height, weight, BMI, percent body fat, and blood pressure. Participants will be asked to return the 3-day diet and supplement diary to the researcher. The researcher will review the diary and ask questions to clarify foods recorded. The participant will then be asked to complete a physical activity questionnaire. Next, supplements will be distributed. The participants will not have knowledge of which group they are assigned to. Group I will receive 168 capsules, each capsule containing 1 gram of wheat germ oil, in two pill bottles. One bottle will contain 100 capsules; the second bottle will contain 68 capsules. Group II will receive 168 capsules, each capsule containing 1 gram of pumpkin seed oil, in two pill bottles. One bottle will contain 100 capsules; the second bottle will contain 68 capsules. Participants will be instructed to take 2 capsules per day, every day for 12 weeks. Two capsules per day are equal to approximately a ½ teaspoon or 18 kilocalories. It does not matter if they choose to take each capsule at the same time or at different times during the day. To help remind participants to take their supplements each day, they will receive a 7 day pill organizer and a daily check list. At this session, participants will receive a second 3-day diet and supplement diary that is to be completed one week before the final session. At the end of the second session, the researcher will schedule the final session with the participant.
The third and final session will take place 12 weeks after the initial session. Measurements taken during the final session will be height, weight, BMI, percent body fat, and blood pressure. The participant will be asked to complete a food frequency questionnaire identical the questionnaire filled out during the first session with the researcher. Participant will be asked to return their 3-day diet and supplement diary, daily check list, pill organizer, 2 pill bottles, and any unused supplements. After completion of the study the participant will receive a $20 Target gift card at this session.
A potential risk of this study includes loss of confidentiality. Confidentiality will be maintained by the use of code numbers rather than names on data containing documents. Digital data analyses will be done using only code numbers and not identifiable data. Data recorded on paper containing identifiable and non-identifiable participant information (consent forms, data collection forms, 3-day diet and supplement diaries, physical activity questionnaires, food frequency questionnaires, and participant daily checklists) will be kept in a locked cabinet in Room 10132B in the Texas Woman's University, Houston Office of Research.
Another potential risk of this study may be that the participant's normal schedule is disrupted by coming to the Texas Woman's University, Houston campus. To minimize this risk, sessions will be scheduled with the researcher in advance Monday through Friday, from 8 a.m. to 5 p.m. to accommodate the participant's schedule.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Texas Woman's University, Institute of Health Sciences- Houston Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Read, speak, and write English
- Premenopausal
Exclusion Criteria:
- Consuming estrogen supplements
- Taking hypertensive blood pressure medication
- Consuming pumpkin seed oil supplements
- Consuming pumpkin seeds more than once a month
- Wheat allergy or gluten intolerance
- Blood pressure > 140/90 mmHg
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: Wheat Germ Oil
Participants will be instructed to consume 2 wheat germ oil capsules ,2g, per day for 12 weeks.
|
2 grams per day, everyday for 12 weeks.
|
EXPERIMENTAL: Pumpkin Seed Oil
Participants will be instructed to consume 2 pumpkin seed oil capsules ,2g, per day for 12 weeks
|
2 grams per day, everyday for 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change From Baseline Systolic Blood Pressure at 12 weeks
Time Frame: Baseline, 12 weeks
|
Baseline, 12 weeks
|
Change From Baseline Diastolic Blood Pressure at 12 weeks
Time Frame: Baseline, 12 weeks
|
Baseline, 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body Mass Index (BMI)
Time Frame: Baseline
|
BMI is an important measurement to record because an increase in weight may be accompanied by an increase in blood pressure.
|
Baseline
|
Percent Body Fat
Time Frame: Baseline
|
Percent body fat is an important measurement to record because an increase in body fat may be accompanied by an increase in blood pressure.
|
Baseline
|
Nutrient content of diet
Time Frame: Baseline
|
Participants will be given instructions on how to keep a 3-day diet and supplement diary.
A booklet will be provided to help them record their diet for two nonconsecutive week days and one weekend day.
Diet will then be analyzed using Minnesota Nutrition Data System for calories, carbohydrate, protein, fat, vitamins, minerals, and phytoestrogen content.
|
Baseline
|
Phytoestrogen content of diet
Time Frame: Baseline
|
A food frequency questionnaire will be given to each participants to assess the phytoestrogen content of her diet.
|
Baseline
|
Activity Level
Time Frame: Baseline
|
The purpose of the physical activity questionnaire is to establish each participant's activity level because physical activity level may have an effect on blood pressure.
|
Baseline
|
Body Mass Index (BMI)
Time Frame: 12 weeks
|
BMI is an important measurement to record because an increase in weight may be accompanied by an increase in blood pressure.
|
12 weeks
|
Percent Body Fat
Time Frame: 12 weeks
|
Percent body fat is an important measurement to record because an increase in body fat may be accompanied by an increase in blood pressure.
|
12 weeks
|
Nutrient content of diet
Time Frame: 12 weeks
|
Participants will be given instructions on how to keep a 3-day diet and supplement diary.
A booklet will be provided to help them record their diet for two nonconsecutive week days and one weekend day.
Diet will then be analyzed using Minnesota Nutrition Data System for calories, carbohydrate, protein, fat, vitamins, minerals, and phytoestrogen content.
|
12 weeks
|
Phytoestrogen content of diet
Time Frame: 12 weeks
|
A food frequency questionnaire will be given to each participants to assess the phytoestrogen content of her diet.
|
12 weeks
|
Activity Level
Time Frame: 12 weeks
|
The purpose of the physical activity questionnaire is to establish each participant's activity level because physical activity level may have an effect on blood pressure.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Samantha L Caudill, BS, Texas Woman's University
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 17411a
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Pressure
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
DongGuk UniversityActive, not recruitingHypertension | Blood Pressure | Ambulatory Blood Pressure | Home Blood Pressure MeasurementKorea, Republic of
-
University of JordanCompletedBlood Pressure | Heart Rate | Airway PressureJordan
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
Istituto Auxologico ItalianoRecruitingArterial Hypertension | Ambulatory Blood Pressure Monitoring | Blood Pressure Determination | Home Blood Pressure MonitoringItaly
-
RadiRad Co., Ltd.Hualien Tzu Chi General HospitalNot yet recruitingBlood Pressure
-
Riphah International UniversityRecruiting
-
GE HealthcareNot yet recruiting
-
Guangdong Provincial People's HospitalRecruiting
-
Guangdong Provincial People's HospitalRecruiting
Clinical Trials on Wheat Germ Oil
-
University of JenaMartin-Luther-Universität Halle-WittenbergCompletedVitamin D3 DeficiencyGermany
-
IRCCS Eugenio MedeaDMF srl (Dietetic Metabolic Food)CompletedAttention Deficit Hyperactivity DisorderItaly
-
Universidade do PortoCenter for Health Technology and Services Research; Project VALORINTEGRADOR...CompletedHealthy VolunteersPortugal
-
Southeast University, ChinaZhongda Hospital; Chinese Nutrition SocietyActive, not recruitingMetabolic Diseases | Dyslipidemias | Oxidative Stress | Immune System Disorder | Fatty Acid Metabolism DisorderChina
-
Azienda di Servizi alla Persona di PaviaCompletedAthletes | Sports
-
University of California, DavisNational Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Clinical Stage III Cutaneous Melanoma... and other conditionsUnited States
-
Western Michigan UniversityGlaxoSmithKlineCompletedMuscle Inflammation | Muscle DamageUnited States
-
Soroka University Medical CenterUnknownSecond Stage of LaborIsrael
-
Sheba Medical CenterUnknownHormone Refractory Prostate CancerIsrael
-
University of MilanCompleted